EN
Home/Start here/It's for a family member
Reading path3 guides, in order

Someone in my family might need a GLP-1. How do I help?

For anyone helping a parent, partner or relative decide, and then supporting them through it.

GLP Guidebook teamUpdated 12 Oct 20264 min read13 sourcesWritten from published sources
The short answer

Read the basics together, talk without blame, and go to the appointment with them. Weight is driven by genes and surroundings, not just willpower. GLP-1 medicines are usually long-term, cost about AED 744 to AED 1,734 a month at the fixed national prices, and insurance rarely pays for weight loss. Older parents need extra care with fluids, low sugar and muscle.

Read this page first. It covers how to bring it up, who pays, what to watch for in an older parent and whether to go to the appointment. At the end, three guides take you further, in order.
On this page
  1. Talking without shame
  2. Who pays, and for how long
  3. An older parent
  4. Going to the appointment
  5. The risks, in brief
  6. What to read next
  7. Sources

How do I bring it up without shame?

Talk about health and how they feel, not how they look. And drop the blame.

A group of international experts agreed that obesity is not a choice.1 It comes mainly from genes and the world around us.1

Shame also backfires. People who fear being judged are less likely to seek care.1

  • Avoid words like "lazy" or "greedy", even as a joke. The experts' pledge rejects them.1
  • Start from what they care about: energy, knees, sugar levels, keeping up with grandchildren.
  • Ask "How can I help?" rather than telling them what to do.
  • Ask before you share their health with other relatives.

Who pays, and for how long?

Plan for a monthly cost that may run for years, not weeks.

Most of the weight usually returns after stopping. In a follow-up of the main semaglutide 2.4 mg (Wegovy) trial, people regained about two-thirds of it within a year of stopping.2 So agree early who pays, and for how long.

  • Medicine prices are fixed nationally, so they're the same at every pharmacy.3,4
  • A Mounjaro pen (4 weekly doses) costs AED 1,734 at every strength. A Wegovy pen costs from AED 743.50 at the starting doses to AED 1,712 at 2.4 mg, on Abu Dhabi's official drug list from 2 October 2026.3
  • Insurance rarely helps for weight: Dubai's basic plan excludes weight-loss medicines, and in Abu Dhabi they are covered for obesity only through the Thiqa programme for UAE nationals.5,6

Tests, doctor visits and any programme fees add to it. Guide 6 has the official prices and a year's cost.

What should I watch for in an older parent?

Older adults do take these medicines. Watch three things closely: fluids, low sugar and muscle.

In the main Ozempic trials, 744 people, about 1 in 4 of those taking part, were 65 or older. No overall differences in safety or effect were seen between older and younger people.7

  • Fluids. Vomiting or diarrhoea can dry them out and harm the kidneys.7 Check they're drinking enough, especially in summer heat and if they fast in Ramadan.8
  • Low sugar. If they take insulin or a sulfonylurea (an older diabetes tablet such as glimepiride), the risk of a hypo (low blood sugar) goes up.7 Learn the signs: dizziness, sweating, shakiness, confusion.7
  • Muscle. Part of the weight lost is lean mass (everything that isn't fat, including muscle), and older age raises the risk of muscle loss (sarcopenia).9 Ask the doctor about protein and safe exercise.
  • Other tablets. These medicines slow the stomach, which can change how other tablets are absorbed.7 Keep a full list of everything they take.

Should I go to the appointment with them?

If they'd like you there, yes. You can help them remember what was said, and ask the questions they might not.

Book the right kind of doctor. Any of these medicines needs a prescription from a doctor licensed in the UAE.10 In Abu Dhabi, a doctor certified in obesity management decides when to start one for weight.11 If they have diabetes, their diabetes doctor should be involved, because other diabetes medicines may need to change.7

Take with you

  • A list of all their medicines, including herbal ones and supplements
  • Recent reports: HbA1c, kidney tests, blood pressure readings
  • "Which medicine and dose, and why this one?"
  • "Which side effects should we call you about?"
  • "How will we know it's working, and when do we review?"
  • "What will it cost each month, all-in, and will insurance pay any of it?"
If they have diabetesShould they consider it?Cost calculator

What to read next, in order

These three guides go deeper. Each one ends with a link to the next, so you can read them one after another.

  1. 1Do I have obesity? Weight and health in the UAEGuide 1 of 9UnderstandUnderstand their numbers first: the BMI and waist numbers UAE doctors use, and the links with diabetes.
  2. 2Should I consider a GLP-1? And when not toGuide 4 of 9DecideWho doctors may consider for a GLP-1, and the reasons not to, including age and kidneys.
  3. 3Side effects and risksGuide 5 of 9DecideKnow the side effects together, so you both know which ones need help fast.
Was this page easy to understand?

Sources

  1. Rubino F et al. Joint international consensus statement for ending stigma of obesity. Nature Medicine, 2020;26:485–497. Statements 6.2 and 10.3, and Box 1. Declared interests: 15 of 36 authors declare ties to Novo Nordisk and 2 to Eli Lilly; Novo Nordisk was one of the sponsors of the meeting's travel costs (paper's own declaration). Full text
  2. Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022;24(8):1553–1564. 327 people followed for a year after stopping. DOI
  3. Department of Health – Abu Dhabi. Shafafiya drug price list (Drugs.xlsx), released 26 September 2026, effective 2 October 2026: official "Package Price to Public" for each pack named here, each listed as a prescription-only medicine ("POM"). Downloaded and checked 12 October 2026. shafafiyaportal.doh.gov.ae (XLSX)
  4. Mondaq (law firm analysis). Pricing of pharmaceutical products in the United Arab Emirates (prices fixed at registration by a Ministry committee, with "fixed margins for the distributors and pharmacies"). 29 September 2016; older than the 2025 medicines law. mondaq.com
  5. Cigna. Essential Benefits Plan (Dubai Health Authority basic plan), table of benefits: medicines "As per DHA formulary", maximum AED 2,500 a year with 30% co-insurance; exclusions 8 ("Surgical and non-surgical treatment for obesity (including morbid obesity), and any other weight control programs, services, or supplies") and 9 ("pharmacological weight reduction regimens"). Checked 12 October 2026. PDF
  6. Daman (National Health Insurance Company). Adjudication guideline: Glucagon-like Peptide-1 (GLP-1) Receptor agonist, version 5, effective 15 January 2023, revised 19 April 2026 (table of GLP-1 brands and approved uses; diabetes cover needs HbA1c 6.5% or more, cardiovascular disease or risk factors, and at least 6 months on metformin or other agents; prior approval; first supply one month; prescribers in internal medicine, endocrinology, family medicine or cardiology; obesity medicines covered only within the Thiqa obesity programme). Checked 12 October 2026. PDF
  7. Novo Nordisk. Ozempic (semaglutide) injection, US prescribing information and Medication Guide, revised May 2026. Sections 4, 5.3, 5.5, 5.6, 7.2, 8.5. (US label; the UAE label is not published online.) PDF
  8. Gulf News. Can you take Ozempic while fasting during Ramadan? UAE experts weigh in (plan dosing with a doctor before Ramadan; pause dose increases; drink 2–3 litres between Iftar and Suhoor; seek review for persistent vomiting, severe abdominal pain or dehydration). 16 February 2026. gulfnews.com
  9. Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes, Obesity and Metabolism, 2024;26(Suppl 4):16–27. DOI
  10. Department of Health – Abu Dhabi. Circular 48/2026, 16 March 2026, relaying an alert on fake GLP-1 products ("GLP-1 receptor agonists … are prescription-only medicines and should only be used under medical supervision"; unregistered products sold online and on social media; report to [email protected]). Summarised, not reproduced. doh.gov.ae
  11. Department of Health – Abu Dhabi. Standard for Non-Surgical Management of Obesity, DOH/ST/HPS/Non-Surgical-MO/V1/2025, February 2025 (GLP-1 starting criteria: BMI 30 or more with a weight-related comorbidity, or over 40; "The obesity certified physician determines the initiation time of pharmacological treatment"; continue beyond 6 months only with at least 5% weight loss; Asian origin and BMI over 23). Checked 12 October 2026. doh.gov.ae
  12. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). NEJM, 2021;384:989–1002. 1,961 adults without diabetes, 68 weeks. DOI
  13. Novo Nordisk. Wegovy (semaglutide) US prescribing information, revised June 2026. Sections 1, 2.2, 5.2, 5.3, 5.5, 8.3, 17. (US label.) PDF

Last checked 12 Oct 2026 · Next review due Jan 2027

How this page was made. Written by the GLP Guidebook team from the sources above: drug labels, published trials, UAE health-authority and insurance documents, official prices and named news reports. It's general information, not medical advice. Talk to a qualified doctor before starting, stopping or changing any medicine. In a medical emergency, call 998 for an ambulance, or 999. How we write